Financials

  • Market Capitalization 83.1 M
  • Employee 162
  • Founded 2015
  • CEO N/A
  • Website www.gossamerbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00MVWLLM2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.13
Rapporto prezzo/fatturato
14.62

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4019
MAIA
MAIA Biotechnology, Inc. Common Stock
1.39 USD-1.42%0.00%+11.20%-33.17%84.55 M USD
4021
ACET
Adicet Bio, Inc. - Common Stock
9.01 USD+0.67%-4.35%+8.82%+1070.13%84.35 M USD
4037
TENX
Tenax Therapeutics, Inc. - Common Stock
2.19 USD+3.30%+21.67%-86.14%-70.99%81.96 M USD
4039
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.19 USD+1.71%+5.31%0.00%-16.20%81.84 M USD

Notizie